Oct. 17 at 4:53 PM
$AVTR partners with BlueWhale Bio — a promising step for CAR-T therapy? 🤔
Despite shares being down 30.8% YTD, this strategic move could enhance Avantor's role in cell therapy, leveraging its bioprocessing strength and BlueWhale's CDNP technology to streamline production and drive long-term growth. 📈
Discover the full potential here 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-body-16643&ADID=SYND_STOCKTWITS_TWEET_2_2771361_BODY_16643